MediciNova Receives Gene Therapy Milestone Payments
MediciNova Receives Gene Therapy Milestone Payments LA JOLLA, Calif., April 22, 2021 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received two milestone payments under MediciNova’s assignment agreement with Genzyme Corporation, a subsidiary of Sanofi. The milestone payments, which total $4 million, are a result of the success...
Geoff Obrien Exchange Commission Medicinova Inc Genzyme Corporation Tokyo Stock Exchange Code Number
Source: forextv.com